Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a StAT3-dependent manner

Thomas A. Mace, Zeenath Ameen, Amy Collins, Sylwia Wojcik, Markus Mair, Gregory S. Young, James R. Fuchs, Tim D. Eubank, Wendy L. Frankel, Tanios Bekaii-Saab, Mark Bloomston, Gregory B. Lesinski

Research output: Contribution to journalArticle

178 Citations (Scopus)

Abstract

Pancreatic stellate cells (PSC) are a subset of pancreatic cancer-associated fibroblasts. These cells provide prosurvival signals to tumors; however, little is known regarding their interactions with immune cells within the tumor microenvironment. We hypothesized that factors produced by human PSC could enhance myeloid-derived suppressor cell (MDSC) differentiation and function, which promotes an immunosuppressive microenvironment. Primary PSC cell lines (n 1/4 7) were generated from human specimens and phenotypically confirmed via expression of vimentin, a-smooth muscle actin (a-SMA), and glial fibrillary acidic protein (GFAP). Luminex analysis indicated that PSC but not human fetal primary pancreatic fibroblast cells (HPF; negative controls) produced MDSC-promoting cytokines [interleukin (IL-6), VEGF, macrophage colony-stimulating factor (M-CSF) ] and chemokines (SDF-1, MCP-1). Culture of peripheral blood mononuclear cells [peripheral blood mononuclear cell (PBMC), n 1/4 3 donors] with PSC supernatants or IL-6/granulocyte macrophage colony-stimulating factor (GM-CSF; positive control) for 7 days promoted PBMC differentiation into an MDSC (CD11b+CD33+) phenotype and a subpopulation of polymorphonuclear CD11b+CD33+CD15+ cells. The resulting CD11b+CD33+ cells functionally suppressed autologous T-lymphocyte proliferation. In contrast, supernatants from HPF did not induce an MDSC phenotype in PBMCs. Culture of normal PBMCs with PSC supernatants led to STAT3 but not STAT1 or STAT5 phosphorylation. IL-6 was an important mediator as its neutralization inhibited PSC supernatant-mediated STAT3 phosphorylation and MDSC differentiation. Finally, the FLLL32 STAT3 inhibitor abrogated PSC supernatant-mediated MDSC differentiation, PSC viability, and reduced autocrine IL-6 production indicating these processes are STAT3 dependent. These results identify a novel role for PSC in driving immune escape in pancreatic cancer and extend the evidence that STAT3 acts as a driver of stromal immunosuppression to enhance its interest as a therapeutic target. Cancer Res; 73(10); 3007-18.

Original languageEnglish (US)
Pages (from-to)3007-3018
Number of pages12
JournalCancer Research
Volume73
Issue number10
DOIs
StatePublished - May 15 2013
Externally publishedYes

Fingerprint

Pancreatic Stellate Cells
Pancreatic Neoplasms
Cell Differentiation
Interleukin-6
Blood Cells
Granulocyte-Macrophage Colony-Stimulating Factor
Phosphorylation
Myeloid-Derived Suppressor Cells
Phenotype
Macrophage Colony-Stimulating Factor
Tumor Microenvironment
Glial Fibrillary Acidic Protein
Vimentin
Immunosuppressive Agents
Chemokines
Immunosuppression
Vascular Endothelial Growth Factor A
Smooth Muscle
Actins
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a StAT3-dependent manner. / Mace, Thomas A.; Ameen, Zeenath; Collins, Amy; Wojcik, Sylwia; Mair, Markus; Young, Gregory S.; Fuchs, James R.; Eubank, Tim D.; Frankel, Wendy L.; Bekaii-Saab, Tanios; Bloomston, Mark; Lesinski, Gregory B.

In: Cancer Research, Vol. 73, No. 10, 15.05.2013, p. 3007-3018.

Research output: Contribution to journalArticle

Mace, TA, Ameen, Z, Collins, A, Wojcik, S, Mair, M, Young, GS, Fuchs, JR, Eubank, TD, Frankel, WL, Bekaii-Saab, T, Bloomston, M & Lesinski, GB 2013, 'Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a StAT3-dependent manner', Cancer Research, vol. 73, no. 10, pp. 3007-3018. https://doi.org/10.1158/0008-5472.CAN-12-4601
Mace, Thomas A. ; Ameen, Zeenath ; Collins, Amy ; Wojcik, Sylwia ; Mair, Markus ; Young, Gregory S. ; Fuchs, James R. ; Eubank, Tim D. ; Frankel, Wendy L. ; Bekaii-Saab, Tanios ; Bloomston, Mark ; Lesinski, Gregory B. / Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a StAT3-dependent manner. In: Cancer Research. 2013 ; Vol. 73, No. 10. pp. 3007-3018.
@article{c68de3a08efa4ea0b9c9816dd8e69803,
title = "Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a StAT3-dependent manner",
abstract = "Pancreatic stellate cells (PSC) are a subset of pancreatic cancer-associated fibroblasts. These cells provide prosurvival signals to tumors; however, little is known regarding their interactions with immune cells within the tumor microenvironment. We hypothesized that factors produced by human PSC could enhance myeloid-derived suppressor cell (MDSC) differentiation and function, which promotes an immunosuppressive microenvironment. Primary PSC cell lines (n 1/4 7) were generated from human specimens and phenotypically confirmed via expression of vimentin, a-smooth muscle actin (a-SMA), and glial fibrillary acidic protein (GFAP). Luminex analysis indicated that PSC but not human fetal primary pancreatic fibroblast cells (HPF; negative controls) produced MDSC-promoting cytokines [interleukin (IL-6), VEGF, macrophage colony-stimulating factor (M-CSF) ] and chemokines (SDF-1, MCP-1). Culture of peripheral blood mononuclear cells [peripheral blood mononuclear cell (PBMC), n 1/4 3 donors] with PSC supernatants or IL-6/granulocyte macrophage colony-stimulating factor (GM-CSF; positive control) for 7 days promoted PBMC differentiation into an MDSC (CD11b+CD33+) phenotype and a subpopulation of polymorphonuclear CD11b+CD33+CD15+ cells. The resulting CD11b+CD33+ cells functionally suppressed autologous T-lymphocyte proliferation. In contrast, supernatants from HPF did not induce an MDSC phenotype in PBMCs. Culture of normal PBMCs with PSC supernatants led to STAT3 but not STAT1 or STAT5 phosphorylation. IL-6 was an important mediator as its neutralization inhibited PSC supernatant-mediated STAT3 phosphorylation and MDSC differentiation. Finally, the FLLL32 STAT3 inhibitor abrogated PSC supernatant-mediated MDSC differentiation, PSC viability, and reduced autocrine IL-6 production indicating these processes are STAT3 dependent. These results identify a novel role for PSC in driving immune escape in pancreatic cancer and extend the evidence that STAT3 acts as a driver of stromal immunosuppression to enhance its interest as a therapeutic target. Cancer Res; 73(10); 3007-18.",
author = "Mace, {Thomas A.} and Zeenath Ameen and Amy Collins and Sylwia Wojcik and Markus Mair and Young, {Gregory S.} and Fuchs, {James R.} and Eubank, {Tim D.} and Frankel, {Wendy L.} and Tanios Bekaii-Saab and Mark Bloomston and Lesinski, {Gregory B.}",
year = "2013",
month = "5",
day = "15",
doi = "10.1158/0008-5472.CAN-12-4601",
language = "English (US)",
volume = "73",
pages = "3007--3018",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a StAT3-dependent manner

AU - Mace, Thomas A.

AU - Ameen, Zeenath

AU - Collins, Amy

AU - Wojcik, Sylwia

AU - Mair, Markus

AU - Young, Gregory S.

AU - Fuchs, James R.

AU - Eubank, Tim D.

AU - Frankel, Wendy L.

AU - Bekaii-Saab, Tanios

AU - Bloomston, Mark

AU - Lesinski, Gregory B.

PY - 2013/5/15

Y1 - 2013/5/15

N2 - Pancreatic stellate cells (PSC) are a subset of pancreatic cancer-associated fibroblasts. These cells provide prosurvival signals to tumors; however, little is known regarding their interactions with immune cells within the tumor microenvironment. We hypothesized that factors produced by human PSC could enhance myeloid-derived suppressor cell (MDSC) differentiation and function, which promotes an immunosuppressive microenvironment. Primary PSC cell lines (n 1/4 7) were generated from human specimens and phenotypically confirmed via expression of vimentin, a-smooth muscle actin (a-SMA), and glial fibrillary acidic protein (GFAP). Luminex analysis indicated that PSC but not human fetal primary pancreatic fibroblast cells (HPF; negative controls) produced MDSC-promoting cytokines [interleukin (IL-6), VEGF, macrophage colony-stimulating factor (M-CSF) ] and chemokines (SDF-1, MCP-1). Culture of peripheral blood mononuclear cells [peripheral blood mononuclear cell (PBMC), n 1/4 3 donors] with PSC supernatants or IL-6/granulocyte macrophage colony-stimulating factor (GM-CSF; positive control) for 7 days promoted PBMC differentiation into an MDSC (CD11b+CD33+) phenotype and a subpopulation of polymorphonuclear CD11b+CD33+CD15+ cells. The resulting CD11b+CD33+ cells functionally suppressed autologous T-lymphocyte proliferation. In contrast, supernatants from HPF did not induce an MDSC phenotype in PBMCs. Culture of normal PBMCs with PSC supernatants led to STAT3 but not STAT1 or STAT5 phosphorylation. IL-6 was an important mediator as its neutralization inhibited PSC supernatant-mediated STAT3 phosphorylation and MDSC differentiation. Finally, the FLLL32 STAT3 inhibitor abrogated PSC supernatant-mediated MDSC differentiation, PSC viability, and reduced autocrine IL-6 production indicating these processes are STAT3 dependent. These results identify a novel role for PSC in driving immune escape in pancreatic cancer and extend the evidence that STAT3 acts as a driver of stromal immunosuppression to enhance its interest as a therapeutic target. Cancer Res; 73(10); 3007-18.

AB - Pancreatic stellate cells (PSC) are a subset of pancreatic cancer-associated fibroblasts. These cells provide prosurvival signals to tumors; however, little is known regarding their interactions with immune cells within the tumor microenvironment. We hypothesized that factors produced by human PSC could enhance myeloid-derived suppressor cell (MDSC) differentiation and function, which promotes an immunosuppressive microenvironment. Primary PSC cell lines (n 1/4 7) were generated from human specimens and phenotypically confirmed via expression of vimentin, a-smooth muscle actin (a-SMA), and glial fibrillary acidic protein (GFAP). Luminex analysis indicated that PSC but not human fetal primary pancreatic fibroblast cells (HPF; negative controls) produced MDSC-promoting cytokines [interleukin (IL-6), VEGF, macrophage colony-stimulating factor (M-CSF) ] and chemokines (SDF-1, MCP-1). Culture of peripheral blood mononuclear cells [peripheral blood mononuclear cell (PBMC), n 1/4 3 donors] with PSC supernatants or IL-6/granulocyte macrophage colony-stimulating factor (GM-CSF; positive control) for 7 days promoted PBMC differentiation into an MDSC (CD11b+CD33+) phenotype and a subpopulation of polymorphonuclear CD11b+CD33+CD15+ cells. The resulting CD11b+CD33+ cells functionally suppressed autologous T-lymphocyte proliferation. In contrast, supernatants from HPF did not induce an MDSC phenotype in PBMCs. Culture of normal PBMCs with PSC supernatants led to STAT3 but not STAT1 or STAT5 phosphorylation. IL-6 was an important mediator as its neutralization inhibited PSC supernatant-mediated STAT3 phosphorylation and MDSC differentiation. Finally, the FLLL32 STAT3 inhibitor abrogated PSC supernatant-mediated MDSC differentiation, PSC viability, and reduced autocrine IL-6 production indicating these processes are STAT3 dependent. These results identify a novel role for PSC in driving immune escape in pancreatic cancer and extend the evidence that STAT3 acts as a driver of stromal immunosuppression to enhance its interest as a therapeutic target. Cancer Res; 73(10); 3007-18.

UR - http://www.scopus.com/inward/record.url?scp=84877848590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877848590&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-12-4601

DO - 10.1158/0008-5472.CAN-12-4601

M3 - Article

C2 - 23514705

AN - SCOPUS:84877848590

VL - 73

SP - 3007

EP - 3018

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 10

ER -